欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号AT/H/1026/002
药品名称Lafene 50 Mikrogramm/Stunde transdermales Pflaster
活性成分
    • fentanyl 5.5 mg
剂型Transdermal patch
上市许可持有人Gebro Pharma GmbH Bahnhofbichl 13 6391 Fieberbrunn Austria
参考成员国 - 产品名称Austria (AT)
Lafene 50 Mikrogramm/Stunde transdermales Pflaster
互认成员国 - 产品名称
    • Luxembourg (LU)
    • Romania (RO)
      Fentanyl Pfizer 50 micrograme/h plasture transdermic
    • Denmark (DK)
    • Ireland (IE)
    • Spain (ES)
    • Portugal (PT)
许可日期2010/04/30
最近更新日期2024/04/18
药物ATC编码
    • N02AB03 fentanyl
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase